Co-Authors
This is a "connection" page, showing publications co-authored by VALERIA SMITH and JENNIFER FOSTER.
Connection Strength
1.217
-
High-Risk Neuroblastoma Treatment Review. Children (Basel). 2018 Aug 28; 5(9).
Score: 0.676
-
Severe COVID-19 infection in a child receiving immunotherapy for cancer. Pediatr Blood Cancer. 2021 03; 68(3):e28710.
Score: 0.195
-
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatr Blood Cancer. 2020 10; 67(10):e28417.
Score: 0.193
-
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. Cancer. 2022 08 01; 128(15):2967-2977.
Score: 0.055
-
Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience. Pediatr Blood Cancer. 2021 09; 68(9):e29173.
Score: 0.051
-
Blood product administration during high risk neuroblastoma therapy. Pediatr Hematol Oncol. 2020 Feb; 37(1):5-14.
Score: 0.046